<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02842762</url>
  </required_header>
  <id_info>
    <org_study_id>108176</org_study_id>
    <nct_id>NCT02842762</nct_id>
  </id_info>
  <brief_title>3D Echocardiographic Assessment of Epicardial Pacing After Cardiopulmonary Bypass.</brief_title>
  <official_title>The Hemodynamic Effect of Transient Epicardial Right Ventricular Pacing After Cardiopulmonary Bypass, Assessed by Real-time Three-dimensional Echocardiography.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Suzanne Flier, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lawson Health Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the usefulness of 3D echocardiography to guide pacemaker therapy in the
      operating room in cardiac surgical patients. Each patient will serve as his own control,
      following a paired design.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiac surgical patients sometimes require temporary pacing wires to optimize cardiac
      function during weaning from cardiopulmonary bypass (CPB), and/or to treat hemodynamically
      significant brady-arrhythmias. The available patient series report that 8.6% to 23.9% of
      patient undergoing coronary artery bypass grafting (CABG) or valve surgery require temporary
      pacing at some time after CPB. The site of pacemaker wire placement seems to be a crucial
      determinant of cardiac output. In non-surgical patients isolated right ventricular (RV)
      pacing seems to induce electromechanical dyssynchrony of the RV and the left ventricle (LV).
      A normal ventricle in sinus rhythm displays a simultaneous contraction of all segments of the
      heart, so that regional minimal volume (i.e. maximal contraction) will occur at the same
      time. Isolated RV pacing seems to result in a left bundle branch type electrical activation
      sequence, with delayed contraction of some of the segments. The LV, but not the RV, seems to
      negatively affected by this state of dyssynchrony, resulting in decreased cardiac output. In
      surgical patients however, there is not such data available yet. Since isolated RV epicardial
      wire placement is still widely practiced in cardiac surgery, and in our own institution, we
      would like to study the effect of RV pacing on LV synchrony and LV output.

      Again from studies in non-surgical patients receiving resynchronization therapy, we know that
      real-time three-dimensional (3D) echocardiography is very useful to pick up subtle changes in
      LV synchrony and thereby guide synchronization of ventricular contraction. However, to date
      the usefulness of real-time 3D echocardiography to guide pacemaker therapy in cardiac surgery
      is unknown. In the present feasibility study in cardiac surgical patients, we want to
      investigate the acute effects of isolated RV pacing on LV synchrony, and LV output.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 20, 2017</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Actual">December 12, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Sequence of measurements, during sinus rhythm and during pacing is randomized.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Left ventricular systolic dyssynchrony index (SDI)</measure>
    <time_frame>Intraoperative, end of cardiac surgery (duration 10 minutes)</time_frame>
    <description>For each segment of 16 segments excluding the apical cap in a standard 17-segment model, the time to reach regional minimal volume is calculated as a fraction of the total cardiac cycle (RR interval) and expressed as a percentage.10 The standard deviation of these measurements is defined as the SDI. Three-dimensional SDI is therefore the dispersion time to reach the minimum systolic volume (as recommended).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ventricular volumes and ejection fraction</measure>
    <time_frame>Intraoperative, end of cardiac surgery (duration 10 minutes)</time_frame>
    <description>We will obtain a full volume 3D dataset and obtain end diastolic (EDV) and end systolic volume (ESV). By subtracting ESV from EDV we will obtain the ejection fraction (EF).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LVOT blood flow</measure>
    <time_frame>Intraoperative, end of cardiac surgery (duration 10 minutes)</time_frame>
    <description>As a surrogate for cardiac output we will obtain the velocity time integral (VTI) across the left ventricular outflow tract (LVOT)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence and severity of mitral regurgitation</measure>
    <time_frame>Intraoperative, end of cardiac surgery (duration 10 minutes)</time_frame>
    <description>From midesophageal position we will perform a transesophageal echocardiography (TEE) study to interrogate the mitral valve for the presence and severity of mitral regurgitation.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Disorder of Pacing Function</condition>
  <arm_group>
    <arm_group_label>Non-paced</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>cardiac surgery
3D TEE measurements of systolic dyssynchrony
right ventricular epicardial pacemaker lead (off)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Paced</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patient is randomized to the order of measurements taken, and serves as his own control.
cardiac surgery
3D TEE measurements of systolic dyssynchrony
right ventricular epicardial pacemaker lead (on)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Right ventricular epicardial pacing</intervention_name>
    <description>The patient's own heart rate at that moment will be the starting point for the study. Right ventricle pacing will be instituted by selecting a rate that is 5 beats above the patient's own heart rate. We will use a stepwise approach where we increase the pacermaker's rate with steps of 5 beats until we have 100% capture of the pacemaker beats. After waiting for at least one minute of pacing we will obtain a set of measurements.</description>
    <arm_group_label>Paced</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>cardiac surgery</intervention_name>
    <description>Elective cardiac surgery, with use of cardiopulmonary bypass.</description>
    <arm_group_label>Non-paced</arm_group_label>
    <arm_group_label>Paced</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>3D TEE</intervention_name>
    <description>Intraoperatively, all patients will be monitored by means of TEE</description>
    <arm_group_label>Non-paced</arm_group_label>
    <arm_group_label>Paced</arm_group_label>
    <other_name>three-dimensional transesophageal echocardiography</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pacemaker lead</intervention_name>
    <description>All patients will have a epicardial pacemaker lead in situ.</description>
    <arm_group_label>Non-paced</arm_group_label>
    <arm_group_label>Paced</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patient scheduled to undergo elective cardiac surgery by means of full
             sternotomy and use of cardiopulmonary bypass

          -  Preoperative moderate to good LV function, ejection fraction &gt; 30%

          -  Age &gt; 18 yrs. old

          -  Preoperative sinus rhythm

          -  Pacemaker lead inserted by cardiac surgeon during surgery

          -  Underlying sinus rhythm after cardiopulmonary bypass before the end of surgery

          -  Able to understand written and verbal patient information

          -  Signed informed consent

        Exclusion Criteria:

          -  Emergency cardiac surgery

          -  Minimally invasive surgery

          -  Contraindication to TEE

          -  Redo surgery

          -  Hemodynamic instability after CPB (late exclusion criterium)

          -  No pacemaker lead inserted by cardiac surgeon (late exclusion criterium)

          -  No sinus rhythm during chest closure towards the end of surgery (late exclusion
             criterium)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Suzanne Flier, MD MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>London Health Sciences Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital - London Health Sciences Centre</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5A5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Wolber T, Haegeli L, Huerlimann D, Brunckhorst C, LÃ¼scher TF, Duru F. Altered left ventricular contraction pattern during right ventricular pacing: assessment using real-time three-dimensional echocardiography. Pacing Clin Electrophysiol. 2011 Jan;34(1):76-81. doi: 10.1111/j.1540-8159.2010.02908.x. Epub 2010 Oct 14.</citation>
    <PMID>20946287</PMID>
  </reference>
  <reference>
    <citation>Kapetanakis S, Kearney MT, Siva A, Gall N, Cooklin M, Monaghan MJ. Real-time three-dimensional echocardiography: a novel technique to quantify global left ventricular mechanical dyssynchrony. Circulation. 2005 Aug 16;112(7):992-1000. Epub 2005 Aug 8.</citation>
    <PMID>16087800</PMID>
  </reference>
  <reference>
    <citation>Alwaqfi NR, Ibrahim KS, Khader YS, Baker AA. Predictors of temporary epicardial pacing wires use after valve surgery. J Cardiothorac Surg. 2014 Feb 12;9:33. doi: 10.1186/1749-8090-9-33.</citation>
    <PMID>24521215</PMID>
  </reference>
  <reference>
    <citation>Bethea BT, Salazar JD, Grega MA, Doty JR, Fitton TP, Alejo DE, Borowicz LM Jr, Gott VL, Sussman MS, Baumgartner WA. Determining the utility of temporary pacing wires after coronary artery bypass surgery. Ann Thorac Surg. 2005 Jan;79(1):104-7.</citation>
    <PMID>15620924</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 20, 2016</study_first_submitted>
  <study_first_submitted_qc>July 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 25, 2016</study_first_posted>
  <last_update_submitted>April 11, 2018</last_update_submitted>
  <last_update_submitted_qc>April 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Lawson Health Research Institute</investigator_affiliation>
    <investigator_full_name>Suzanne Flier, MD</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Echocardiography, Three-dimensional</keyword>
  <keyword>Cardiac Surgical Procedures</keyword>
  <keyword>Cardiac Pacing, Artificial</keyword>
  <keyword>Anesthesia</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

